One ayahuasca experience could have lasting effects on the brain

New research suggests just one trip can change parts of the brain related to mood.

One ayahuasca experience may be all it takes to leave a lasting change on the brain, new research suggests.

The study, published in the dopely-named Journal of Psychopharmacology, found lasting changes in parts of the brain that deal with higher-order cognitive functions, like creativity, concept learning, and decision making.

Researchers took 50 subjects who had never had an ayahuasca experience before, giving some a low dose of the psychedelic and others a placebo. They took functional MRI scans — which show activity in the brain by tracking blood flow — on the day before, and the day after, the subject’s ayahuasca experience.

The scans found that “the psychedelic experience induced by ayahuasca has a lasting effect on the functional organization of brain networks supporting higher order cognitive and affective functions,” Lorenzo Pasquini, study author and postdoctoral fellow at the Memory and Aging Center at the University of California, San Francisco, told PsyPost.

Meaning, just one ayahuasca experience may impact parts of the brain concerned with complicated thinking and emotions. According to PsyPost, the research suggests ayahuasca may cause long-lasting effects on mood.

More specifically, the psychedelic concoction — long used by Indigenous tribes in the Amazon, recently co-opted by techbro types — had an impact on two regions of the brain that are concerned with introspection (perceiving sensations from inside your body, like your stomach churning), emotions, and motivational functions.

The parts of the brain concerned with the senses, meanwhile, remained unaffected after one dose.

The study is not without its drawbacks, deficiencies pretty common to the world of neuroscience and psychedelic research. 50 subjects is a pretty small sample size, and the magnetic field strength of the scanners left a little to be desired. 

“The field would greatly profit from replication studies with larger samples using state-of-the-art facilities,” Pasquini told PsyPost.

Like fellow psychedelics MDMA, ketamine, psilocybin, and LSD, an ayahuasca experience may prove a promising treatment for psychiatric disorders. Pasquini hopes the research may help provide a framework for further considering psychedelic therapy’s potential to treat mood and personality disorders.

“The revival of psychedelic research of the last years provides an exciting opportunity to study the clinical potential of psychedelic therapy sessions on mood disorders affecting millions of persons worldwide,” Pasquini said.

Related
‘Mad honey’: The rare hallucinogen from the mountains of Nepal
On the mountainsides of Nepal and Turkey, bees sometimes produce a strange and dangerous concoction: mad honey.
AI maps psychedelic “trip” experiences to regions of the brain – opening new route to psychiatric treatments 
To better understand how these effects manifest in the brain, we analyzed over 6,000 written testimonials of hallucinogenic experiences.
Closeup of a woman placing a pill in her mouth.
How the antidepressant Prozac could treat blindness
Prozac is a widely used antidepressant. Data indicates that the drug could be used to prevent blindness due to macular degeneration.
A close-up of a pipette
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
It’s disappointing when the years of effort and resources spent to push a drug candidate to patients so often lead to failure.
A pile of empty prescription pill bottles.
Opioid overdose: A bioethicist explains why restricting supply may not be the right solution
Since the unpredictability of drug supply increases overdose risk, making the drug supply predictable should be part of the solution, right?
Up Next
Afghan Farmers Solar Panels Opium
Subscribe to Freethink for more great stories